SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-048469
Filing Date
2024-04-17
Accepted
2024-04-17 21:38:26
Documents
2
Group Members
SYNTONE LLCSYNTONE TECH NOLOGIES GROUP CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2412152d1_sc13da.htm SC 13D/A 62073
2 EXHIBIT 1 tm2412152d1_ex1.htm EX-99.1 6342
  Complete submission text file 0001104659-24-048469.txt   70182
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Subject) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-89495 | Film No.: 24852660
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1517 CHAMPLAIN CREST WAY CARY NC 27513
Business Address 1517 CHAMPLAIN CREST WAY CARY NC 27513 781-308-0823
Syntone Ventures LLC (Filed by) CIK: 0001814394 (see all company filings)

IRS No.: 851021604 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A